Synthesis of docosasaccharide arabinan motif of mycobacterial cell wall

Journal of the American Chemical Society

Volumn 133, Issue 7, 2011, Pages 2275-2291

  Ishiwata, Akihiro ^a   Ito, Yukishige ^a,b  

^a RIKEN   (Japan)

^b JAPAN SCIENCE AND TECHNOLOGY AGENCY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ARABINANS; ARABINOGALACTAN; FRAGMENT COUPLING; GLYCOSYL DONORS; LINEAR SEQUENCE; LIPOARABINOMANNANS; MONOMER UNITS; MYCOBACTERIAL; MYCOBACTERIAL CELLS; STEREO-SELECTIVE; SYNTHETIC STRATEGIES; THIOGLYCOSIDES;

ETHERS;

1,2 ACETONIDE; ACETONIDE; AGLYCONE; BETA ARABINOFURANOSYL; DOCOSASACCHARIDE ARABINAN; GLUCOCORTICOID; HEPTADECASACCHARIDE; OCTASACCHARIDE; POLYSACCHARIDE; THIOGLYCOSIDE; UNCLASSIFIED DRUG;

ARTICLE; BACTERIAL CELL WALL; GLYCOSYLATION; MYCOBACTERIUM; SEQUENCE ANALYSIS; STEREOCHEMISTRY; STRUCTURE ANALYSIS; SYNTHESIS;

AMINO ACID MOTIFS; CARBOHYDRATE SEQUENCE; CELL WALL; MODELS, MOLECULAR; MOLECULAR SEQUENCE DATA; MYCOBACTERIUM; POLYSACCHARIDES; STEREOISOMERISM;

EID: 79951819296     PISSN: 00027863     EISSN: 15205126     Source Type: Journal    
DOI: 10.1021/ja109932t     Document Type: Article

References (66)

1. Recent reviews on biologically relevant furanosides, see: (a) Peltier, P.; Euzen, R.; Daniellou, R.; Nugier-Chauvin, C.; Ferrières, V. Carbohydr. Res. 2008, 343, 1897-1923.
2. (b) Richards, M. R.; Lowary, T. L. ChemBioChem 2009, 10, 1920-1938.
3. (a) Brennan, P. J.; Nikaido, H. Annu. Rev. Biochem. 1995, 64, 29-63.
4. (b) Ratledge, C., Jeremy, D., Eds. Mycobacteria, Molecular Biology and Virulence; Blackwell Science: Oxford, 1999.
5. (c) Cole, S. T., Eisenach, K. D., McMurray, D. N., Jacobs, W. R., Jr., Eds. Tuberculosis and the Tubercle Bacillus; ASM Press: Washington, DC, 2005.
6. Notermans, S.; Veeneman, G. H.; Van Zuylen, C. W. E. M.; Hoogerhout, P.; Van Boom, J. H. Mol. Immunol. 1998, 25, 975-979.
7. de Lederkremer, R. M.; Colli, W. Glycobiology 1995, 5, 547-552.
8. Houseknecht, J. B.; Lowary, T. D. Curr. Opin. Chem. Biol. 2001, 5, 677-682.
9. Designed inhibitors againstmycobacterial Araf-T, see: (a) Pathak, A. K.; Pathak, V.; Maddry, J. A.; Suling, W. J.; Gurcha, S. S.; Besra, G. S.; Reynolds, R. C. Bioorg. Med. Chem. 2001, 9, 3145-3151.
10. (b) Pathak, A. K.; Pathak, V.; Kulshrestha, M.; Kinnaird, D.; Suling, W. J.; Gurcha, S. S.; Besra, G. S.; Reynolds, R. C. Tetrahedron 2003, 59, 10239-10248.
11. (c) Wilkinson, B. L.; Long, H.; Sim, E.; Fairbanks, A. J. Bioorg. Med. Chem. Lett. 2008, 18, 6265-6267.
12. (d) Ayers, B.; Long, H.; Sim, E.; Smellie, I. A.; Wilkinson, B. L.; Fairbanks, A. J. Carbohydr. Res. 2009, 344, 739-746.
13. (a) Anti-Tuberculosis drug resistance in the world; World Health Organization: Geneva, 2000.
14. (b) WHO Report 2004, Global tuberculosis control-surveillance, planning, financing; World Health Organization: Geneva, 2004.
15. (c) Chiang, C.-Y.; Yew, W. W. Int. J. Tuberc. Lung Dis. 2009, 13, 304-311.
16. Alexandroff, A. B.; Jackson, A. M.; O'Donnell, M. A.; James, K. Lancet 1999, 353, 1689-1694.
17. Mathe, G.; Halle-Pannenko, O.; Bourut, C. Natl. Cancer Inst. Monogr. 1973, 39, 107-113.
18. (a) Tsuji, S.; Matsumoto, M.; Takeuchi, O.; Akira, S.; Azuma, I.; Hayashi, A.; Toyoshima, K.; Seya, T. Infect. Immun. 2000, 68, 6883-6890.
19. (b) Recent review, see: Krieg, A. M. Nat. Med. 2003, 9, 831-835.
20. Besra, G. S.; Khoo, K.-H.; McNeil, M.; Dell, A.; Morris, R.; Brennan, P. J. Biochemistry 1995, 34, 4257-4266.
21. (a) Draper, P.; Khoo, K. H.; Chatterjee, D.; Dell, A.; Morris, H. R. Biochem. J. 1997, 327, 519-525.
22. (b) Alderwick, L. J.; Radmacher, E.; Seidel, M.; Gande, R.; Hitchen, P. G.; Morris, H. R.; Dell, A.; Sahm, H.; Eggeling, L.; Besra, G. S. J. Biol. Chem. 2005, 280, 32362-32371.
23. (c) Lee, A.; Wu, S. W.; Scherman, M. S.; Torrelles, J. B.; Chatterjee, D.; McNeil, M. R.; Khoo, K.-H. Biochemistry 2006, 45, 15817-15828.
24. (d) Alderwick, L. J.; Seidel, M.; Sahm, H.; Besra, G. S.; Eggeling, L. J. Biol. Chem. 2006, 281, 15652-15661.
25. (e) Shi, L. B.; Berg, S.; Lee, A.; Spencer, J. S.; Zhang, J.; Vissa, V.; McNeil, M. R.; Khoo, K. H.; Chatterjee, D. J. Biol. Chem. 2006, 281, 19512-19526.
26. (f) Bhamidi, S.; Scherman, M. S.; Rithner, C. D.; Prenni, J. E.; Chatterjee, D.; Koo, K.-H.; McNeil, M. R. J. Biol. Chem. 2008, 283, 12992-13000.
27. Matsuzaki, Y.; Ito, Y.; Nakahara, Y.; Ogawa, T. Tetrahedron Lett. 1993, 34, 1061-1064.
28. Fraser-Reid, B.; Jayaprakash, J. L. K. N.; López, J. C. Tetrahedron: Asymmetry 2006, 17, 2449-2463.
29. Joe, M.; Bai, Y.; Nacario, R. C.; Lowary, T. L. J. Am. Chem. Soc. 2007, 129, 9885-9901.
30. 17 (29%), we designed so as to conduct all fragment couplings at linear sequences.
31. For recent examples for fragment coupling using thioglycoside of a branched trisaccharide, see: Pragani, R.; Seeberger, P. H. J. Am. Chem. Soc. 2011, 133, 102-107.
32. Kanie, O.; Ito, Y.; Ogawa, T. J. Am. Chem. Soc. 1994, 116, 12073-12074.
33. Callam, C. S.; Gadikota, R. R.; Krein, D. M.; Lowary, T. L. J. Am. Chem. Soc. 2003, 125, 13112-13119.
34. Lee, Y. J.; Lee, K.; Jung, E. H.; Jeon, H. B.; Kim, K. S. Org. Lett. 2005, 7, 3263-3266.
35. Zhu, X.; Kawatkar, S.; Rao, Y.; Boons, G.-J. J. Am. Chem. Soc. 2006, 128, 11948-11957.
36. Ishiwata, A.; Akao, H.; Ito, Y. Org. Lett. 2006, 8, 5525-5528.
37. Crich, D.; Pedersen, C. M.; Bowers, A. A.; Wink, D. J. J. Org. Chem. 2007, 72, 1553-1565.
38. Wang, Y.; Maguire-Boyle, S.; Dere, R. T.; Zhu, X. Carbohydr. Res. 2008, 343, 3100-3106.
39. Imamura, A.; Lowary, T. L. Org. Lett. 2010, 12, 3686-3689.
40. (a) Désiré, J.; Prandi, J. Carbohydr. Res. 1999, 317, 110-118.
41. (b) Bamhaoud, T.; Sanchez, S.; Prandi, J. Chem. Commun. 2000, 659-660.
42. (c) Sanchez, S.; Bamhaoud, T.; Prandi, J. Tetrahedron Lett. 2000, 41, 7447-7452.
43. (d) Marotte, K.; Sanchez, S.; Bamhauold, T.; Prandi, J. Eur. J. Org. Chem. 2003, 3587-3598.
44. Ishiwata, A.; Munemura, Y.; Ito, Y. Eur. J. Org. Chem. 2008, 64, 4250-4263.
45. Reviews, see: (a) Jung, K.; Müller, M.; Schmidt, R. R. Chem. Rev. 2000, 100, 4423-4442.
46. (b) Gridley, J. J.; Osborn, M. I. J. Chem. Soc., Perkin Trans. 1 2000, 1471-1491.
47. (c) Davis, B. G. J. Chem. Soc., Perkin Trans. 1 2000, 2137-2160.
48. (d) Cumpstey, I. Carbohydr. Res. 2008, 343, 1553-1573.
49. (e) Carmona, A. T.; Moreno-Vargas, A. J.; Robina, I. Curr. Org. Synth. 2008, 5, 33-63.
50. (f) Ishiwata, A.; Lee, Y. J.; Ito, Y. Org. Biomol. Chem. 2010, 8, 3596-3608.
51. Garegg, P. J. Adv. Carbohydr. Chem. Biochem. 1997, 52, 179-205.
52. Ishiwata, A.; Akao, H.; Ito, Y.; Sunagawa, M.; Kusunose, N.; Kashiwazaki, Y. Bioorg. Med. Chem. 2006, 14, 3049-3061.
53. See the Supporting Information.
54. Guilford, W. J.; Copley, S. D.; Knowles, J. R. J. Am. Chem. Soc. 1987, 109, 5013-5019.
55. D'Souza, F. W.; Lowary, T. L. Org. Lett. 2000, 2, 1493-1495.
56. D'Souza, F. W.; Ayers, J. D.; McCarren, P. R.; Lowary, T. L. J. Am. Chem. Soc. 2000, 122, 1251-1260.
57. Frigell, J.; Cumpstey, I. Tetrahedron Lett. 2007, 48, 9073-9076.
58. (a) Woodward, R. B.; et al. J. Am. Chem. Soc. 1981, 103, 3215-3217.
59. (b) Nakata, M.; Tamai, T.; Kamio, T.; Kinoshita, M.; Tatsuta, K. Bull. Chem. Soc. Jpn. 1994, 67, 3057-3066.
60. (c) Fürstner, A. Liebigs Ann. Chem. 1993, 1211-1217.
61. (d) Mereyala, H. B.; Hotha, S.; Gurjar, M. K. J. Chem. Soc., Chem. Commun. 1998, 685-686.
62. 7]Bn, all these signals disappear, and the isomeric ratio of glycosylated products can be estimated easily by relative intensities of anomeric signals, especially in case that a trace amount of undesired 1,2-trans glycoside was formed. Ishiwata, A.; Ito, Y. Tetrahedron Lett. 2005, 46, 3521-3524.
63. 7 (43) was synthesized from tolyl (methyl) 2,3-di-O-benzyl-1- thio-D-arabinofuranoside in one step (NaH, NAPBr). For the experimental procedure, see the Supporting Information.
64. Bols, M.; Hansen, H. C. Chem. Lett. 1994, 1049-1052.
65. This basic condition was first reported for deprotection of phthalimide. Kanie, O.; Crawley, S. C.; Palcic, M. M.; Hindsgaul, O. Carbohydr. Res. 1993, 243, 139-164.
66. For NMR studies of free arabinan, see ref 15. Also see: Lee, R. E. B.; Lee, W.; Chatterjee, D.; Lee, R. E. Glycobiology 2005, 15, 139-151.